These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
657 related items for PubMed ID: 26748531
1. A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD. Janssen TW, Bink M, Geladé K, van Mourik R, Maras A, Oosterlaan J. J Child Psychol Psychiatry; 2016 May; 57(5):633-44. PubMed ID: 26748531 [Abstract] [Full Text] [Related]
2. A Randomized Controlled Trial Investigating the Effects of Neurofeedback, Methylphenidate, and Physical Activity on Event-Related Potentials in Children with Attention-Deficit/Hyperactivity Disorder. Janssen TW, Bink M, Geladé K, van Mourik R, Maras A, Oosterlaan J. J Child Adolesc Psychopharmacol; 2016 May; 26(4):344-53. PubMed ID: 26771913 [Abstract] [Full Text] [Related]
3. Behavioral Effects of Neurofeedback Compared to Stimulants and Physical Activity in Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial. Geladé K, Janssen TW, Bink M, van Mourik R, Maras A, Oosterlaan J. J Clin Psychiatry; 2016 Oct; 77(10):e1270-e1277. PubMed ID: 27631143 [Abstract] [Full Text] [Related]
5. An RCT into the effects of neurofeedback on neurocognitive functioning compared to stimulant medication and physical activity in children with ADHD. Geladé K, Bink M, Janssen TW, van Mourik R, Maras A, Oosterlaan J. Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):457-468. PubMed ID: 27665293 [Abstract] [Full Text] [Related]
6. Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD. Bioulac S, Purper-Ouakil D, Ros T, Blasco-Fontecilla H, Prats M, Mayaud L, Brandeis D. BMC Psychiatry; 2019 Aug 01; 19(1):237. PubMed ID: 31370811 [Abstract] [Full Text] [Related]
7. Learning curves of theta/beta neurofeedback in children with ADHD. Janssen TWP, Bink M, Weeda WD, Geladé K, van Mourik R, Maras A, Oosterlaan J. Eur Child Adolesc Psychiatry; 2017 May 01; 26(5):573-582. PubMed ID: 27866283 [Abstract] [Full Text] [Related]
8. Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder. Loo SK, Bilder RM, Cho AL, Sturm A, Cowen J, Walshaw P, Levitt J, Del'Homme M, Piacentini J, McGough JJ, McCracken JT. J Am Acad Child Adolesc Psychiatry; 2016 Aug 01; 55(8):674-682.e1. PubMed ID: 27453081 [Abstract] [Full Text] [Related]
9. A 6-month follow-up of an RCT on behavioral and neurocognitive effects of neurofeedback in children with ADHD. Geladé K, Janssen TWP, Bink M, Twisk JWR, van Mourik R, Maras A, Oosterlaan J. Eur Child Adolesc Psychiatry; 2018 May 01; 27(5):581-593. PubMed ID: 29098467 [Abstract] [Full Text] [Related]
10. Effectiveness of neurofeedback versus medication for attention-deficit/hyperactivity disorder. Sudnawa KK, Chirdkiatgumchai V, Ruangdaraganon N, Khongkhatithum C, Udomsubpayakul U, Jirayucharoensak S, Israsena P. Pediatr Int; 2018 Sep 01; 60(9):828-834. PubMed ID: 29931709 [Abstract] [Full Text] [Related]
11. Neurocognitive effects of neurofeedback in adolescents with ADHD: a randomized controlled trial. Bink M, van Nieuwenhuizen C, Popma A, Bongers IL, van Boxtel GJ. J Clin Psychiatry; 2014 May 01; 75(5):535-42. PubMed ID: 24922488 [Abstract] [Full Text] [Related]
12. Neurofeedback and standard pharmacological intervention in ADHD: a randomized controlled trial with six-month follow-up. Meisel V, Servera M, Garcia-Banda G, Cardo E, Moreno I. Biol Psychol; 2013 Sep 01; 94(1):12-21. PubMed ID: 23665196 [Abstract] [Full Text] [Related]
13. Neurofeedback training aimed to improve focused attention and alertness in children with ADHD: a study of relative power of EEG rhythms using custom-made software application. Hillard B, El-Baz AS, Sears L, Tasman A, Sokhadze EM. Clin EEG Neurosci; 2013 Jul 01; 44(3):193-202. PubMed ID: 23820311 [Abstract] [Full Text] [Related]
14. A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder. van Dongen-Boomsma M, Vollebregt MA, Slaats-Willemse D, Buitelaar JK. J Clin Psychiatry; 2013 Aug 01; 74(8):821-7. PubMed ID: 24021501 [Abstract] [Full Text] [Related]
15. Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial. Purper-Ouakil D, Blasco-Fontecilla H, Ros T, Acquaviva E, Banaschewski T, Baumeister S, Bousquet E, Bussalb A, Delhaye M, Delorme R, Drechsler R, Goujon A, Häge A, Kaiser A, Mayaud L, Mechler K, Menache C, Revol O, Tagwerker F, Walitza S, Werling AM, Bioulac S, Brandeis D. J Child Psychol Psychiatry; 2022 Feb 01; 63(2):187-198. PubMed ID: 34165190 [Abstract] [Full Text] [Related]
16. A proposed multisite double-blind randomized clinical trial of neurofeedback for ADHD: need, rationale, and strategy. Kerson C, Collaborative Neurofeedback Group. J Atten Disord; 2013 Jul 01; 17(5):420-36. PubMed ID: 23590978 [Abstract] [Full Text] [Related]
17. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan. Takahashi N, Koh T, Tominaga Y, Saito Y, Kashimoto Y, Matsumura T. World J Biol Psychiatry; 2014 Aug 01; 15(6):488-98. PubMed ID: 24456065 [Abstract] [Full Text] [Related]
20. Additive effects of neurofeedback on the treatment of ADHD: A randomized controlled study. Lee EJ, Jung CH. Asian J Psychiatr; 2017 Feb 01; 25():16-21. PubMed ID: 28262140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]